Medico Remedies Limited (MEDICO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs6.43 Million ≈ $69.54K USD) by net assets (Rs668.58 Million ≈ $7.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medico Remedies Limited - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medico Remedies Limited (MEDICO) total liabilities for a breakdown of total debt and financial obligations.

Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Rockhaven Resources Ltd
V:RK
-0.001x
Borneo Oil Bhd
KLSE:7036
0.004x
Fokus Mining Corp
V:FKM
-0.026x
HAMMONIA Schiffsholding AG
HM:HHX
0.000x
Concraft Holding Co Ltd
TW:4943
-0.033x
Lake Victoria Gold Ltd.
V:LVG
-0.030x
Wonpoong Corporation
KQ:008370
0.052x
Hwashin Precision Engineering Co. Ltd
KQ:126640
-0.029x

Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Medico Remedies Limited worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs624.69 Million
≈ $6.76 Million
Rs48.92 Million
≈ $529.06K
0.078x +68.23%
2024-03-31 Rs523.71 Million
≈ $5.66 Million
Rs24.38 Million
≈ $263.65K
0.047x -75.01%
2023-03-31 Rs438.43 Million
≈ $4.74 Million
Rs81.67 Million
≈ $883.25K
0.186x +18.60%
2022-03-31 Rs373.20 Million
≈ $4.04 Million
Rs58.62 Million
≈ $633.95K
0.157x +145.08%
2021-03-31 Rs324.58 Million
≈ $3.51 Million
Rs-113.10 Million
≈ $-1.22 Million
-0.348x -1175.78%
2020-03-31 Rs298.66 Million
≈ $3.23 Million
Rs9.67 Million
≈ $104.62K
0.032x -81.43%
2019-03-31 Rs282.36 Million
≈ $3.05 Million
Rs49.24 Million
≈ $532.54K
0.174x -8.75%
2018-03-31 Rs266.66 Million
≈ $2.88 Million
Rs50.97 Million
≈ $551.17K
0.191x +202.51%
2017-03-31 Rs163.72 Million
≈ $1.77 Million
Rs-30.52 Million
≈ $-330.12K
-0.186x +26.28%
2016-03-31 Rs147.44 Million
≈ $1.59 Million
Rs-37.29 Million
≈ $-403.27K
-0.253x -980.71%
2015-03-31 Rs136.14 Million
≈ $1.47 Million
Rs-3.19 Million
≈ $-34.46K
-0.023x -107.36%
2014-03-31 Rs85.72 Million
≈ $927.00K
Rs27.27 Million
≈ $294.96K
0.318x -21.78%
2013-03-31 Rs50.55 Million
≈ $546.71K
Rs20.57 Million
≈ $222.40K
0.407x --

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic
Market Cap
$38.12 Million
Rs3.53 Billion INR
Market Cap Rank
#22847 Global
#1271 in India
Share Price
Rs42.48
Change (1 day)
+4.63%
52-Week Range
Rs32.76 - Rs55.85
All Time High
Rs96.70
About

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more